Fig. 4.
Fig. 4. Telomerase activity in lymph nodes and bone marrow from HIV-infected patients. (A) Telomerase activity in extracts equivalent to 105, 104, and 103 purified CD4+ and CD8+ T cells isolated from PB (CD4 and CD8) and lymph node tissue (LN, CD4 and CD8) shown for one representative HIV-infected individual. (B) Telomerase activity in CD4+ and CD8+ T cells isolated from PB and LN from four HIV-infected individuals, as analyzed by the original TRAP assay. (C) Telomerase activity in extracts equivalent to 104, 103, and 102 total bone marrow cells from two HIV-infected patients after AIDS diagnosis and two HIV− controls. Total bone marrow cell samples contained approximately 40% to 45% CD3+ cells, 4% CD19+ cells, and 2% CD34+ cells. In bone marrow samples from the AIDS patients, the percentage of CD4+ cells was decreased (6.5% compared with 15% in HIV− samples) and the percentage CD8+ cells was increased (30% compared with 18%).

Telomerase activity in lymph nodes and bone marrow from HIV-infected patients. (A) Telomerase activity in extracts equivalent to 105, 104, and 103 purified CD4+ and CD8+ T cells isolated from PB (CD4 and CD8) and lymph node tissue (LN, CD4 and CD8) shown for one representative HIV-infected individual. (B) Telomerase activity in CD4+ and CD8+ T cells isolated from PB and LN from four HIV-infected individuals, as analyzed by the original TRAP assay. (C) Telomerase activity in extracts equivalent to 104, 103, and 102 total bone marrow cells from two HIV-infected patients after AIDS diagnosis and two HIV controls. Total bone marrow cell samples contained approximately 40% to 45% CD3+ cells, 4% CD19+ cells, and 2% CD34+ cells. In bone marrow samples from the AIDS patients, the percentage of CD4+ cells was decreased (6.5% compared with 15% in HIV samples) and the percentage CD8+ cells was increased (30% compared with 18%).

Close Modal

or Create an Account

Close Modal
Close Modal